These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3895878)

  • 1. Clinical safety of intravenous amrinone--a review.
    Treadway G
    Am J Cardiol; 1985 Jul; 56(3):39B-40B. PubMed ID: 3895878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous use of amrinone for the treatment of the failing heart.
    Mancini D; LeJemtel T; Sonnenblick E
    Am J Cardiol; 1985 Jul; 56(3):8B-15B. PubMed ID: 2411122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amrinone--a new inotropic agent in chronic resistant congestive cardiac failure.
    Robinson PJ; Lvoff R; Chong B; Barrett PA
    Aust N Z J Med; 1981 Dec; 11(6):666-8. PubMed ID: 6949545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with amrinone in patients with advanced congestive heart failure.
    Kinney EL; Carlin B; Ballard JO; Burks JM; Hallahan WF; Zelis R
    J Clin Pharmacol; 1982 Oct; 22(10):433-40. PubMed ID: 7174853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Side effects of amrinone therapy.
    Wilsmhurst PT; Webb-Peploe MM
    Br Heart J; 1983 May; 49(5):447-51. PubMed ID: 6838732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-glycoside, non-catecholamine inotropic agents in the treatment of congestive heart failure.
    Tommaso CL
    Am J Med; 1986 Feb; 80(2B):36-9. PubMed ID: 3004210
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of amrinone administered orally and by injection in heart failure].
    Bounhoure JP; Massabuau P; Puel J; Miquel JP; Calazel J
    Ann Med Interne (Paris); 1985; 136(3):251-5. PubMed ID: 3896092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amrinone-mediated thrombocytopenia.
    Kinney EL; Ballard JO; Carlin B; Zelis R
    Scand J Haematol; 1983 Oct; 31(4):376-80. PubMed ID: 6622977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical effects and side effects of amrinone. A study of 24 patients with chronic congestive heart failure.
    Silverman BD; Merrill AJ; Gerber L
    Arch Intern Med; 1985 May; 145(5):825-9. PubMed ID: 3994460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous amrinone for congestive heart failure.
    Med Lett Drugs Ther; 1984 Nov; 26(675):104-5. PubMed ID: 6390109
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical effects of intravenous amrinone in patients with congestive heart failure.
    Goldstein RA
    Circulation; 1986 Mar; 73(3 Pt 2):III191-5. PubMed ID: 3510775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral amrinone for the treatment of chronic congestive heart failure: results of a multicenter randomized double-blind and placebo-controlled withdrawal study.
    DiBianco R; Shabetai R; Silverman BD; Leier CV; Benotti JR
    J Am Coll Cardiol; 1984 Nov; 4(5):855-66. PubMed ID: 6386932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial.
    Massie B; Bourassa M; DiBianco R; Hess M; Konstam M; Likoff M; Packer M
    Circulation; 1985 May; 71(5):963-71. PubMed ID: 3886191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative vasoactive therapy for heart failure.
    Benotti JR; McCue JE; Alpert JS
    Am J Cardiol; 1985 Jul; 56(3):19B-24B. PubMed ID: 4025154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amrinone therapy for congestive heart failure in outpatients with idiopathic dilated cardiomyopathy.
    Leier CV; Dalpiaz K; Huss P; Hermiller JB; Magorien RD; Bashore TM; Unverferth DV
    Am J Cardiol; 1983 Aug; 52(3):304-8. PubMed ID: 6683463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiologic effects of amrinone.
    Goldstein RA; Gray EL; Dougherty AH; Naccarelli GV
    Am J Cardiol; 1985 Jul; 56(3):25B-28B. PubMed ID: 4025155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous amrinone in left ventricular failure complicated by acute myocardial infarction.
    Taylor SH; Verma SP; Hussain M; Reynolds G; Jackson NC; Hafizullah M; Richmond A; Silke B
    Am J Cardiol; 1985 Jul; 56(3):29B-32B. PubMed ID: 4025156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intracoronary and intravenous amrinone infusions in patients with cardiac failure and patients with near normal cardiac function.
    Wilmshurst PT; Thompson DS; Juul SM; Dittrich HC; Dawson JR; Walker JM; Jenkins BS; Coltart DJ; Webb-Peploe MM
    Br Heart J; 1985 May; 53(5):493-506. PubMed ID: 3994862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug.
    Hermiller JB; Leithe ME; Magorien RD; Unverferth DV; Leier CV
    J Pharmacol Exp Ther; 1984 Feb; 228(2):319-26. PubMed ID: 6694112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oral amrinone on platelet function and survival.
    Brandt JT; Miller L; Hermiller J; Unverferth DV; Leier CV
    Clin Pharmacol Ther; 1984 Aug; 36(2):260-4. PubMed ID: 6744783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.